RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

The respiratory tract’s microbial microflora plays a significant role in determining the severity of RSV infections and the ...

Research published in late 2024 in the journal JAMA Pediatrics found nirsevimab was more than 90 percent effective at preventing hospitalization for RSV, and 89 percent effective at preventing all ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

“Areas with lower vaccination rates, colder weather and higher population density are seeing higher infection rates,” said Dr ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

If you have children or seniors in your family, you know that we are right in the middle of flu and virus season.

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

It appears RSV and COVID have peaked, but the flu is still rising. The number and rate of positive cases of COVID is notably ...

NHS England announced on Monday that more than one million adults in England, aged between 75 and 79, or those who turned 80 ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...